OncoSil Medical: Presentation, CEO Sessions Sydney

Company Presentations

by Carolyn Herbert

OncoSil Medical (ASX:OSL) is developing an implantable radiotherapy device for the treatment of inoperable pancreatic and liver cancer. 
OncoSil™ is created by melting up to 5% phosphorous in liquid silicon in a furnace. The resultant molten liquid is shattered into small particles using sterile water. The particles are graded by size and 30 micron particles are selected for further use. 
The company has had discussions with the FDA and says its is ready by the end of the year to file for an FDA IDE. Earlier this year Oncosil filed for a CE Mark for European approval. 

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.